Jeffrey A. Bluestone

机构：University of California, San Francisco, University of San Francisco · ORCID：0000-0001-8793-7848

发表论文 670 篇 · 总被引 95006 次 · h-index 159

代表论文

Opportunities for Treg cell therapy for the treatment of human disease (2023 · Frontiers in Immunology · 被引 134)
Harnessing regulatory T cells to establish immune tolerance (2024 · Science Translational Medicine · 被引 51)
Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor–Induced Hypophysitis (2023 · Journal of the Endocrine Society · 被引 28)
Treg cell therapy manufacturability: current state of the art, challenges and new opportunities (2025 · Frontiers in Immunology · 被引 25)
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study (2025 · Journal for ImmunoTherapy of Cancer · 被引 20)
Regulatory T cell therapies to treat autoimmune diseases and transplant rejection (2025 · Nature Immunology · 被引 8)